Phase II data of brigantinib for relapsed and metastatic NSCLC released
Data from the pivotal Phase 2 ALTA clinical trial evaluating brigatinib in patients with crizotinib-refractory, anaplastic lymphoma…
Browsing: lung cancer drug trial
Five-year Survival Rate For Nivolumab-treated Advanced Lung Cancer Patients Much Higher Than Historical Rate
Treatment with the immune checkpoint inhibitor nivolumab (Opdivo) yielded durable responses in some patients with…